Metraipolis › archive › dc_5e017d9869a9
Comparative efficacy and safety of pharmacological treatments for lower-risk myelodysplastic syndromes: a Systematic Review and network meta-analysis — Europe PMC PMID:42382389
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42382389
- DOI
- 10.3389/fonc.2026.1853205
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-19T09:27:48.314Z
- SHA-256 of the archived text
6f117cdc93ef8b38e84f9493cd53813ef1c6b8afa3ba88e562514434eecf20d7- Stable URL of this page
https://metraipolis.com/documento/dc_5e017d9869a9
How to cite
Comparative efficacy and safety of pharmacological treatments for lower-risk myelodysplastic syndromes: a Systematic Review and network meta-analysis — Europe PMC PMID:42382389 — Europe PMC (en), https://europepmc.org/article/MED/42382389 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5e017d9869a9 (Metraipolis archive dc_5e017d9869a9, sha256 6f117cdc93ef8b38e84f9493cd53813ef1c6b8afa3ba88e562514434eecf20d7)
BibTeX
@misc{dc5e017d9869a9,
title = {Comparative efficacy and safety of pharmacological treatments for lower-risk myelodysplastic syndromes: a Systematic Review and network meta-analysis — Europe PMC PMID:42382389},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42382389},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5e017d9869a9; sha256 6f117cdc93ef8b38e84f9493cd53813ef1c6b8afa3ba88e562514434eecf20d7},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42382389. Agents can read the archived copy with the MCP tool read_document.